Skip to main content

UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks

Inquiry

The Coronavirus covid-19 outbreak is the latest in a series of disease outbreaks that have spread internationally, presenting major challenges to communities, national governments and international institutions. 

Scientific knowledge and advice are foundational to the prevention, management and treatment of these global outbreaks, at both an international and national level. 

Once the covid-19 pandemic has passed its peak, it will be necessary for international and national systems to learn from the crisis. The Science and Technology Committee will inquire formally into the place of UK research, science and technology in the national and global response, and what lessons should be learned for the future. 

Read the interactive summary of the report.

Read the call for evidence for more information about this inquiry.

Reports, special reports and government responses

View all reports and responses
First Report - The UK response to covid-19: use of scientific advice
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Committees Science and Technology Committee (Commons)
HC 136
Report

Oral evidence transcripts

View all oral evidence transcripts
28 April 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor John Aston (Harding Professor of Statistics in Public Life at University of Cambridge), Professor Sir Munir Pirmohamed (Chair at Commission on Human Medicines), Professor Anthony Harnden (Deputy Chair at Joint Committee on Vaccination and Immunisation), Dr Mary Ramsay (Head of Immunisation at Public Health England), Dr Ruth Payne (NIHR Academic Clinical Lecturer and Honorary Specialist Registrar in Infectious Diseases and Microbiology at University of Sheffield), Professor Christopher Dye (Professor of Epidemiology at University of Oxford), and Professor Ran Balicer (Director at Clalit Research Institute, and Professor of Public Health at Ben-Gurion University)
Committees Science and Technology Committee (Commons)
Oral Evidence
9 March 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Chris Whitty, Chief Medical Officer for England, and Sir Patrick Vallance, Government Chief Scientific Adviser
Committees Science and Technology Committee (Commons)
Oral Evidence
24 February 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Anthony Harnden (Deputy Chair, Joint Committee on Vaccination and Immunisation and Professor of Primary Care at University of Oxford), Professor Wendy Barclay (Head of the Department of Infectious Disease at Imperial College London), Dr Philip Dormitzer (Vice President and Chief Scientific Officer of Viral Vaccines at Pfizer), Professor Sarah Gilbert (Professor of Vaccinology at University of Oxford), Madelaine McTernan (Director General at UK Vaccine Taskforce), and Nadhim Zahawi (Minister for COVID Vaccine Deployment at Department for Health and Social Care)
Committees Science and Technology Committee (Commons)
Oral Evidence
C190114 - UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Joint Biosecurity Centre
Committees Science and Technology Committee (Commons)
Written Evidence
C190076 - UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Mr Samuel Hilton (Research Affiliate at Centre for the Study of Existential Risk), Toby Ord (Senior Research Fellow at Future of Humanity Institute), and Haydn Belfield (Academic Project Manager at Centre for the Study of Existential Risk)
Committees Science and Technology Committee (Commons)
Written Evidence
C190113 - UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Sylvia Richardson (Director, MRC Biostatistics Unit at Cambridge Institute of Public Health, University of Cambridge)
Committees Science and Technology Committee (Commons)
Written Evidence